In addition, PF4 was shown to be elevated in peripheral artery disease, acute ischemic stroke, essential thrombocytopenia, and other clinical conditions that were associated with platelet activation and is thus considered a relatively more sensitive marker of platelet activation during pathological events [14]. The gene discussed is PF4; the disease is peripheral arterial disease.